GlassScriptPhysician profile
Kimberly M Starks
NPI 1265670335
$4,249.15
in general payments reported to CMS, 2019-2025
22 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,810 · 2022: $1,003 · 2023: $556 · 2024: $565 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,436.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $889.84 | 2021-2024 | Cardiomems, Tacticath Ablation Catheter, Sensor Enabled, Na |
| Amgen INC. | $763.97 | 2021-2024 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $560.52 | 2021-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $434.82 | 2021-2024 | Farxiga |
| Novartis Pharmaceuticals Corporation | $277.47 | 2022-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $223.30 | 2021-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $192.69 | 2024-2025 | Assure Wcd |
| Medtronic, INC. | $188.73 | 2022-2025 | Corevalve Evolut R, Azure Xt Dr Mri Surescan |
| Abiomed | $124.90 | 2025 | |
| Janssen Pharmaceuticals, INC | $119.25 | 2021 | |
| Boston Scientific Corporation | $87.90 | 2021-2022 | |
| Pfizer INC. | $64.25 | 2021 | |
| Davol INC. | $50.93 | 2021 | |
| Daiichi Sankyo INC. | $44.82 | 2021-2022 | |
| Biosense Webster, INC. | $39.72 | 2023 | Octaray Mapping Catheter |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $38.31 | 2024 | Optimizer |
| Bayer Healthcare Pharmaceuticals INC. | $34.44 | 2022 | |
| Amarin Pharma, INC. | $31.15 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $28.94 | 2021-2025 | Eliquis |
| Cardiovascular Systems INC. | $26.42 | 2021-2022 | |
| Novo Nordisk INC | $14.84 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Starks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.